Dogwood Therapeutics
DWTX
13 hedge funds and large institutions have $7.64M invested in Dogwood Therapeutics in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
2,516% more capital invested
Capital invested by funds: $292K → $7.64M (+$7.35M)
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
30% more funds holding
Funds holding: 10 → 13 (+3)
7.78% more ownership
Funds ownership: 3.06% → 10.84% (+7.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$9.65M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$184K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$70K |
| 4 |
Goldman Sachs
New York
|
+$43K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$23.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$39.2K |
| 2 |
Morgan Stanley
New York
|
-$1.98K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $6.92M | +$9.65M | +3,280,000 | New |
|
|
VCM
2
Vanguard Capital Management
Malvern,
Pennsylvania
| $279K | +$389K | +132,154 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $168K | +$184K | +62,655 | +373% |
|
|
VFT
4
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
| $132K | +$185K | +62,736 | New |
|
|
5
Northern Trust
Chicago,
Illinois
| $50.2K | +$70K | +23,779 | New |
|
|
6
Goldman Sachs
New York
| $30.8K | +$43K | +14,598 | New |
|
7
Marshall Wace
London,
United Kingdom
| $24.8K | +$297 | +101 | +0.9% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $17K | +$23.7K | +8,067 | New |
|
9
UBS Group
Zurich,
Switzerland
| $14.9K | +$15.7K | +5,337 | +305% |
|
|
AWM
10
Activest Wealth Management
Aventure,
Florida
| $253 | – | – | – |
|
11
BlackRock
New York
| $63 | – | – | – |
|
12
Group One Trading
Chicago,
Illinois
| $19 | – | – | – |
|
13
BNP Paribas Financial Markets
Paris,
France
| $4 | – | – | – |
|
|
14
Bank of America
Charlotte,
North Carolina
| – | -$39.2K | -9,415 | Closed |
|
|
15
Morgan Stanley
New York
| – | -$1.98K | -477 | Closed |
|
DWTX Hedge Fund Activity: Q1 2026 in Review
13 of the 8,141 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q1 2026, worth a combined $7.64M — up 2,516% from $292K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new DWTX positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $9.65M. The largest seller was Bank of America, exiting entirely with an estimated $39.2K sold.
- 13 institutional investors held Dogwood Therapeutics (DWTX) as of Q1 2026, up from 10 in Q4 2025.
- Funds reported $7.64M of Dogwood Therapeutics stock for Q1 2026, up 2,516% quarter-over-quarter.
- 6 funds opened new Dogwood Therapeutics positions in Q1 2026 and 2 closed out, a net change of +4 holders.
- The largest Dogwood Therapeutics buyer in Q1 2026 was Armistice Capital, an estimated $9.65M added.
- The largest Dogwood Therapeutics seller in Q1 2026 was Bank of America, an estimated $39.2K sold.
Based on aggregated 13F filings for Q1 2026.